Schizophrenic Patients Taking Part in Integrated Care Program (CARE I)

AstraZeneca

Status: Terminated

Conditions: Schizophrenia; Schizoaffective Disorder; Psychotic Disorder Not Otherwise Specified; Schizophreni-form Disorder; Delusional Disorder

Study type: Observational

Funder types: Industry

Identifiers

NCT00617214

NIS-NDE-SER-2007/1

Details and patient eligibility

About

Purpose of this non-interventional study (NIS) is to assess the effect of the participation in an integrated care program on treatment outcomes in patients treated with Seroquel for schizophrenia.

Enrollment: 20 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Outpatients suffering from schizophrenia, schizoaffective disorder, schizophreni-form disorder, delusional disorder or psychotic disorder not otherwise specified
• Age 18 - 65 years
• Current stable treatment with Seroquel according to SmPC since at least 2 months
• Given consent to take part in an integrated care program prior to study startWritten informed consent to take part in this NIS

Exclusion criteria

• Presence of any contraindication as described in the SmPC
• Cancellation of participation in the integrated care program

Trial design

20 participants in 1 patient group

All

Description:

Schizophrenic outpatients who are treated with Seroquel IR and who are additionally intended to start with an integrated care program